The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data

. 2015 Feb ; 265 (1) : 73-82. [epub] 20140522

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid24848366

Current studies suggest that an early improvement of depressive symptoms and the reduction of prefrontal theta cordance value predict the subsequent response to antidepressants. The aim of our study was (1) to compare the predictive abilities of early clinical improvement defined as ≥ 20 % reduction in Montgomery and Åsberg Depression Rating Scale (MADRS) total score at week 1 and 2, and the decrease of prefrontal theta cordance at week 1 in resistant depressive patients and (2) to assess whether the combination of individual predictors yields more robust predictive power than either predictor alone. Eighty-seven subjects were treated (≥ 4 weeks) with various antidepressants chosen according to the judgment of attending psychiatrists. Areas under curve (AUC) were calculated to compare predictive effect of defined single predictors (≥ 20 % reduction in MADRS total score at week 1 and 2, and the decrease of cordance at week 1) and combined prediction models. AUCs of all three predictors were not statistically different (pair-wise comparison). The model combining all predictors yielded an AUC value 0.91 that was significantly higher than AUCs of each individual predictor. The results indicate that the combined predictor model may be a useful and clinically meaningful tool for the prediction of antidepressant response in patients with resistant depression.

Zobrazit více v PubMed

J Affect Disord. 2011 Jan;128(1-2):41-8 PubMed

J Clin Psychiatry. 1997;58 Suppl 13:23-9 PubMed

Neurosci Lett. 1999 Oct 15;274(1):29-32 PubMed

Electroencephalogr Clin Neurophysiol. 1998 Dec;107(6):408-14 PubMed

Eur Neuropsychopharmacol. 2010 Jul;20(7):459-66 PubMed

Biol Psychiatry. 2001 Mar 1;49(5):416-25 PubMed

J Affect Disord. 2009 Oct;117 Suppl 1:S26-43 PubMed

Neuropsychopharmacology. 2011 Jan;36(1):183-206 PubMed

J Affect Disord. 2007 Mar;98(3):215-25 PubMed

J Affect Disord. 2009 Apr;114(1-3):243-53 PubMed

Brain Stimul. 2012 Oct;5(4):569-76 PubMed

Neuroimage. 1994 Jun;1(3):208-19 PubMed

Biol Psychiatry. 2008 Jun 15;63(12):1171-7 PubMed

Psychopharmacology (Berl). 1996 Oct;127(4):291-301 PubMed

J Affect Disord. 2011 Mar;129(1-3):183-90 PubMed

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 PubMed

Eur Neuropsychopharmacol. 2009 Nov;19(11):772-7 PubMed

Electroencephalogr Clin Neurophysiol Suppl. 1999;52:15-20 PubMed

Psychiatry Res. 1994 Sep;55(3):141-52 PubMed

J Clin Psychiatry. 2010 Apr;71(4):451-62 PubMed

Psychiatr Clin North Am. 2007 Mar;30(1):105-24 PubMed

Br Med Bull. 2012;101:127-45 PubMed

Eur Psychiatry. 2008 Aug;23(5):350-5 PubMed

J Clin Psychiatry. 2003 Apr;64(4):413-20 PubMed

Psychiatry Res. 2009 Sep 30;169(2):132-8 PubMed

J Psychiatr Res. 2005 Sep;39(5):461-6 PubMed

Int Rev Psychiatry. 2013 Oct;25(5):604-18 PubMed

Clin EEG Neurosci. 2008 Oct;39(4):175-81 PubMed

Psychol Med. 2010 Aug;40(8):1367-77 PubMed

J Affect Disord. 2010 Jan;120(1-3):86-93 PubMed

Eur Psychiatry. 2013 Aug;28(6):362-71 PubMed

J Clin Psychiatry. 2009 Mar;70(3):344-53 PubMed

Neuropsychopharmacology. 2002 Jul;27(1):120-31 PubMed

CNS Spectr. 2008 Aug;13(8):663-81 PubMed

J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 PubMed

J Affect Disord. 2009 Jun;115(3):439-49 PubMed

World J Biol Psychiatry. 2007;8(2):67-104 PubMed

Eur Psychiatry. 2012 Oct;27(7):522-7 PubMed

J Psychiatr Res. 2009 Jan;43(3):215-29 PubMed

Harv Rev Psychiatry. 2011 May-Jun;19(3):144-54 PubMed

Psychiatry Res. 2009 Sep 30;169(2):124-31 PubMed

Am J Psychiatry. 2002 Jan;159(1):122-9 PubMed

Neuropharmacology. 2012 Jan;62(1):264-9 PubMed

J Clin Psychiatry. 2011 Nov;72(11):1478-84 PubMed

Am J Psychiatry. 2006 Jan;163(1):28-40 PubMed

Am J Psychiatry. 2001 Mar;158(3):405-15 PubMed

J Psychiatr Res. 2007 Apr-Jun;41(3-4):319-25 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):415-20 PubMed

Am J Psychiatry. 2006 Nov;163(11):1905-17 PubMed

CNS Drugs. 2010 Feb;24(2):131-61 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...